01 1Atul Bioscience Ltd
01 1DESVENLAFAXINE SUCCINATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-01-24
Pay. Date : 2023-11-17
DMF Number : 37571
Submission : 2022-11-09
Status : Active
Type : II
20
Atul Bioscience Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is DESVENLAFAXINE SUCCINATE USP, with a corresponding US DMF Number 37571.
Remarkably, this DMF maintains an Active status since its submission on November 09, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2024, and payment made on November 17, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
